Array BioPharma Inc ( ARRY) files its latest 10-K with SEC for the fiscal year ended on June 30, 2017. Array BioPharma Inc is a biopharmaceutical company. It is engaged in the discovery, development ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback